The Centers for Disease Control and Prevention continues to recommend early treatment with antiviral medications for hospitalized patients and high-risk outpatients with flu, including children under 2 years old, the agency said Friday in an advisory. Clinicians also should vaccinate patients for as long as flu viruses are circulating, and promptly start antiviral treatment for severely ill and high-risk patients with suspected flu without waiting for laboratory confirmation, the agency said. Outpatient visits for flu-like illness have been elevated for nine weeks, primarily due to certain influenza B viruses that can cause severe illness in all ages and higher pediatric mortality. Certain influenza A viruses that can cause severe illness also are increasing, CDC said.

Related News Articles

Headline
The Administration for Strategic Preparedness and Response June 25 announced a flu pandemic preparedness and response strategy in response to the threat of…
Headline
The Food and Drug Administration last week granted enforcement discretion for the use of conjunctival swabs by laboratories as part of human testing for H5N1…
Headline
The Centers for Disease Control and Prevention May 21 announced recommendations that flu surveillance systems continue operating at enhanced levels during the…
Headline
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…
Headline
The Home Test to Treat program now offers free testing, telehealth and treatment for both COVID-19 and flu to eligible adults nationwide, the National…
Headline
Flu-associated medical visits and hospitalizations per 100,000 population in 2022-23 were higher among children under age 5 than for older children, but were…